Average Co-Inventor Count = 3.59
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Presidio Pharmaceuticals, Inc. (12 from 12 patents)
2. Sarcode Bioscience Inc. (10 from 25 patents)
3. Sunesis Pharmaceuticals, Inc. (8 from 63 patents)
4. Myokardia, Inc. (7 from 12 patents)
5. Sarcode Corporation (4 from 4 patents)
6. Biogen Ma Inc. (3 from 250 patents)
7. Biogen Idec Ma Inc. (2 from 216 patents)
41 patents:
1. 12459919 - Polymorphic forms of (R)-4-(1-((3-(difluoromethyl)-1-methyl-1H-pyrazol-4-yl)sulfonyl)-1- fluoroethyl)-N-(isoxazol-3-yl)piperidine-1-carboxamide
2. 12344607 - Substituted 5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine-2,4-diones for treating cardiac diseases
3. 11123337 - 4-methylsulfonyl-substituted piperidine urea compounds
4. 11034693 - Substituted 5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine-2,4-diones for treating cardiac diseases
5. 10758525 - 4-methylsulfonyl-substituted piperidine urea compounds
6. 10577374 - Bruton's tyrosine kinase inhibitors
7. 10124000 - Modulators of cellular adhesion
8. 9925177 - 4-methylsulfonyl-substituted piperidine urea compounds
9. 9790229 - Bruton's tyrosine kinase inhibitors
10. 9663516 - Bicyclic-pyrimidinedione compounds
11. 9309260 - Inhibitors of hepatitis C virus
12. 9249146 - Bruton'S tyrosine kinase inhibitors
13. 9248126 - Modulators of cellular adhesion
14. 9216174 - Modulators of cellular adhesion
15. 9150554 - Fused ring inhibitors of hepatitis C